JP Morgan Chase’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-2,890
Closed – – 7540
2022
Q4
$0 Sell
2,890
-242,610
-99% -$111K ﹤0.01% 7275
2022
Q3
$320K Buy
245,500
+39,939
+19% +$85K ﹤0.01% 4715
2022
Q2
$306K Buy
205,561
+203,906
+12,321% +$937K ﹤0.01% 4843
2022
Q1
$14K Buy
+1,655
New +$14.6K ﹤0.01% 6153
2021
Q4
– Sell
-65,934
Closed -$667K – 7157
2021
Q3
$667K Buy
+65,934
New +$662K ﹤0.01% 4561

Other funds holding CORZ

JP Morgan Chase's CORZ Position: Q1 2023 in Review

JP Morgan Chase sold out of Core Scientific, Inc. Common Stock (CORZ) in Q1 2023, closing a stake of 2,890 shares.

JP Morgan Chase first reported a position in CORZ in Q3 2021 and held it in 5 quarters. The position peaked at $667K in Q3 2021. 10 funds tracked by Wall St. Rank hold CORZ as of Q1 2023.

  • JP Morgan Chase reported no remaining Core Scientific, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • JP Morgan Chase sold 2,890 Core Scientific, Inc. Common Stock shares in Q1 2023.
  • JP Morgan Chase first reported a position in Core Scientific, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • JP Morgan Chase's Core Scientific, Inc. Common Stock position peaked at $667K in Q3 2021.
  • 10 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q1 2023.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.